Global Ofatumumab Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Ofatumumab Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Ofatumumab by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Ofatumumab by Country/Region, 2017, 2022 & 2028

2.2 Ofatumumab Segment by Type

2.2.1 Patent

2.2.2 Generic

2.3 Ofatumumab Sales by Type

2.3.1 Global Ofatumumab Sales Market Share by Type (2017-2022)

2.3.2 Global Ofatumumab Revenue and Market Share by Type (2017-2022)

2.3.3 Global Ofatumumab Sale Price by Type (2017-2022)

2.4 Ofatumumab Segment by Application

2.4.1 Chemical

2.4.2 Pharmaceutical

2.5 Ofatumumab Sales by Application

2.5.1 Global Ofatumumab Sale Market Share by Application (2017-2022)

2.5.2 Global Ofatumumab Revenue and Market Share by Application (2017-2022)

2.5.3 Global Ofatumumab Sale Price by Application (2017-2022)

3 Global Ofatumumab by Company

3.1 Global Ofatumumab Breakdown Data by Company

3.1.1 Global Ofatumumab Annual Sales by Company (2020-2022)

3.1.2 Global Ofatumumab Sales Market Share by Company (2020-2022)

3.2 Global Ofatumumab Annual Revenue by Company (2020-2022)

3.2.1 Global Ofatumumab Revenue by Company (2020-2022)

3.2.2 Global Ofatumumab Revenue Market Share by Company (2020-2022)

3.3 Global Ofatumumab Sale Price by Company

3.4 Key Manufacturers Ofatumumab Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Ofatumumab Product Location Distribution

3.4.2 Players Ofatumumab Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Ofatumumab by Geographic Region

4.1 World Historic Ofatumumab Market Size by Geographic Region (2017-2022)

4.1.1 Global Ofatumumab Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Ofatumumab Annual Revenue by Geographic Region

4.2 World Historic Ofatumumab Market Size by Country/Region (2017-2022)

4.2.1 Global Ofatumumab Annual Sales by Country/Region (2017-2022)

4.2.2 Global Ofatumumab Annual Revenue by Country/Region

4.3 Americas Ofatumumab Sales Growth

4.4 APAC Ofatumumab Sales Growth

4.5 Europe Ofatumumab Sales Growth

4.6 Middle East & Africa Ofatumumab Sales Growth

5 Americas

5.1 Americas Ofatumumab Sales by Country

5.1.1 Americas Ofatumumab Sales by Country (2017-2022)

5.1.2 Americas Ofatumumab Revenue by Country (2017-2022)

5.2 Americas Ofatumumab Sales by Type

5.3 Americas Ofatumumab Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Ofatumumab Sales by Region

6.1.1 APAC Ofatumumab Sales by Region (2017-2022)

6.1.2 APAC Ofatumumab Revenue by Region (2017-2022)

6.2 APAC Ofatumumab Sales by Type

6.3 APAC Ofatumumab Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Ofatumumab by Country

7.1.1 Europe Ofatumumab Sales by Country (2017-2022)

7.1.2 Europe Ofatumumab Revenue by Country (2017-2022)

7.2 Europe Ofatumumab Sales by Type

7.3 Europe Ofatumumab Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Ofatumumab by Country

8.1.1 Middle East & Africa Ofatumumab Sales by Country (2017-2022)

8.1.2 Middle East & Africa Ofatumumab Revenue by Country (2017-2022)

8.2 Middle East & Africa Ofatumumab Sales by Type

8.3 Middle East & Africa Ofatumumab Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Ofatumumab

10.3 Manufacturing Process Analysis of Ofatumumab

10.4 Industry Chain Structure of Ofatumumab

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Ofatumumab Distributors

11.3 Ofatumumab Customer

12 World Forecast Review for Ofatumumab by Geographic Region

12.1 Global Ofatumumab Market Size Forecast by Region

12.1.1 Global Ofatumumab Forecast by Region (2023-2028)

12.1.2 Global Ofatumumab Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Ofatumumab Forecast by Type

12.7 Global Ofatumumab Forecast by Application

13 Key Players Analysis

13.1 BOC Sciences

13.1.1 BOC Sciences Company Information

13.1.2 BOC Sciences Ofatumumab Product Offered

13.1.3 BOC Sciences Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 BOC Sciences Main Business Overview

13.1.5 BOC Sciences Latest Developments

13.2 GlaxoSmithKline(GSK)

13.2.1 GlaxoSmithKline(GSK) Company Information

13.2.2 GlaxoSmithKline(GSK) Ofatumumab Product Offered

13.2.3 GlaxoSmithKline(GSK) Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GlaxoSmithKline(GSK) Main Business Overview

13.2.5 GlaxoSmithKline(GSK) Latest Developments

13.3 Lonza Group

13.3.1 Lonza Group Company Information

13.3.2 Lonza Group Ofatumumab Product Offered

13.3.3 Lonza Group Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Lonza Group Main Business Overview

13.3.5 Lonza Group Latest Developments

13.4 Novartis International

13.4.1 Novartis International Company Information

13.4.2 Novartis International Ofatumumab Product Offered

13.4.3 Novartis International Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Novartis International Main Business Overview

13.4.5 Novartis International Latest Developments

13.5 TargetMol Chemicals

13.5.1 TargetMol Chemicals Company Information

13.5.2 TargetMol Chemicals Ofatumumab Product Offered

13.5.3 TargetMol Chemicals Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 TargetMol Chemicals Main Business Overview

13.5.5 TargetMol Chemicals Latest Developments

13.6 Hubei Kele Fine Chemical

13.6.1 Hubei Kele Fine Chemical Company Information

13.6.2 Hubei Kele Fine Chemical Ofatumumab Product Offered

13.6.3 Hubei Kele Fine Chemical Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Hubei Kele Fine Chemical Main Business Overview

13.6.5 Hubei Kele Fine Chemical Latest Developments

13.7 Jiangxi Ruiweier Biotechnology

13.7.1 Jiangxi Ruiweier Biotechnology Company Information

13.7.2 Jiangxi Ruiweier Biotechnology Ofatumumab Product Offered

13.7.3 Jiangxi Ruiweier Biotechnology Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Jiangxi Ruiweier Biotechnology Main Business Overview

13.7.5 Jiangxi Ruiweier Biotechnology Latest Developments

13.8 Nantong Feiyu Biological Technology

13.8.1 Nantong Feiyu Biological Technology Company Information

13.8.2 Nantong Feiyu Biological Technology Ofatumumab Product Offered

13.8.3 Nantong Feiyu Biological Technology Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Nantong Feiyu Biological Technology Main Business Overview

13.8.5 Nantong Feiyu Biological Technology Latest Developments

13.9 Shanghai Biochempartner

13.9.1 Shanghai Biochempartner Company Information

13.9.2 Shanghai Biochempartner Ofatumumab Product Offered

13.9.3 Shanghai Biochempartner Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Shanghai Biochempartner Main Business Overview

13.9.5 Shanghai Biochempartner Latest Developments

13.10 Shanghai Macklin Biochemical

13.10.1 Shanghai Macklin Biochemical Company Information

13.10.2 Shanghai Macklin Biochemical Ofatumumab Product Offered

13.10.3 Shanghai Macklin Biochemical Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Shanghai Macklin Biochemical Main Business Overview

13.10.5 Shanghai Macklin Biochemical Latest Developments

13.11 Shanghai Yifei Biotechnology

13.11.1 Shanghai Yifei Biotechnology Company Information

13.11.2 Shanghai Yifei Biotechnology Ofatumumab Product Offered

13.11.3 Shanghai Yifei Biotechnology Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Shanghai Yifei Biotechnology Main Business Overview

13.11.5 Shanghai Yifei Biotechnology Latest Developments

13.12 Tianmen Hengchang Chemical

13.12.1 Tianmen Hengchang Chemical Company Information

13.12.2 Tianmen Hengchang Chemical Ofatumumab Product Offered

13.12.3 Tianmen Hengchang Chemical Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Tianmen Hengchang Chemical Main Business Overview

13.12.5 Tianmen Hengchang Chemical Latest Developments

13.13 Wuhan Topule Biopharmaceutical

13.13.1 Wuhan Topule Biopharmaceutical Company Information

13.13.2 Wuhan Topule Biopharmaceutical Ofatumumab Product Offered

13.13.3 Wuhan Topule Biopharmaceutical Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Wuhan Topule Biopharmaceutical Main Business Overview

13.13.5 Wuhan Topule Biopharmaceutical Latest Developments

13.14 Wuhan Wogeda Biotechnology

13.14.1 Wuhan Wogeda Biotechnology Company Information

13.14.2 Wuhan Wogeda Biotechnology Ofatumumab Product Offered

13.14.3 Wuhan Wogeda Biotechnology Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Wuhan Wogeda Biotechnology Main Business Overview

13.14.5 Wuhan Wogeda Biotechnology Latest Developments

13.15 Wuhan Yingnuo Pharmaceutical Technology

13.15.1 Wuhan Yingnuo Pharmaceutical Technology Company Information

13.15.2 Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Product Offered

13.15.3 Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Wuhan Yingnuo Pharmaceutical Technology Main Business Overview

13.15.5 Wuhan Yingnuo Pharmaceutical Technology Latest Developments

14 Research Findings and Conclusion

Table 1. Ofatumumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Ofatumumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Patent

Table 4. Major Players of Generic

Table 5. Global Ofatumumab Sales by Type (2017-2022) & (Kg)

Table 6. Global Ofatumumab Sales Market Share by Type (2017-2022)

Table 7. Global Ofatumumab Revenue by Type (2017-2022) & ($ million)

Table 8. Global Ofatumumab Revenue Market Share by Type (2017-2022)

Table 9. Global Ofatumumab Sale Price by Type (2017-2022) & (US$/Kg)

Table 10. Global Ofatumumab Sales by Application (2017-2022) & (Kg)

Table 11. Global Ofatumumab Sales Market Share by Application (2017-2022)

Table 12. Global Ofatumumab Revenue by Application (2017-2022)

Table 13. Global Ofatumumab Revenue Market Share by Application (2017-2022)

Table 14. Global Ofatumumab Sale Price by Application (2017-2022) & (US$/Kg)

Table 15. Global Ofatumumab Sales by Company (2020-2022) & (Kg)

Table 16. Global Ofatumumab Sales Market Share by Company (2020-2022)

Table 17. Global Ofatumumab Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Ofatumumab Revenue Market Share by Company (2020-2022)

Table 19. Global Ofatumumab Sale Price by Company (2020-2022) & (US$/Kg)

Table 20. Key Manufacturers Ofatumumab Producing Area Distribution and Sales Area

Table 21. Players Ofatumumab Products Offered

Table 22. Ofatumumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Ofatumumab Sales by Geographic Region (2017-2022) & (Kg)

Table 26. Global Ofatumumab Sales Market Share Geographic Region (2017-2022)

Table 27. Global Ofatumumab Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Ofatumumab Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Ofatumumab Sales by Country/Region (2017-2022) & (Kg)

Table 30. Global Ofatumumab Sales Market Share by Country/Region (2017-2022)

Table 31. Global Ofatumumab Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Ofatumumab Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Ofatumumab Sales by Country (2017-2022) & (Kg)

Table 34. Americas Ofatumumab Sales Market Share by Country (2017-2022)

Table 35. Americas Ofatumumab Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Ofatumumab Revenue Market Share by Country (2017-2022)

Table 37. Americas Ofatumumab Sales by Type (2017-2022) & (Kg)

Table 38. Americas Ofatumumab Sales Market Share by Type (2017-2022)

Table 39. Americas Ofatumumab Sales by Application (2017-2022) & (Kg)

Table 40. Americas Ofatumumab Sales Market Share by Application (2017-2022)

Table 41. APAC Ofatumumab Sales by Region (2017-2022) & (Kg)

Table 42. APAC Ofatumumab Sales Market Share by Region (2017-2022)

Table 43. APAC Ofatumumab Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Ofatumumab Revenue Market Share by Region (2017-2022)

Table 45. APAC Ofatumumab Sales by Type (2017-2022) & (Kg)

Table 46. APAC Ofatumumab Sales Market Share by Type (2017-2022)

Table 47. APAC Ofatumumab Sales by Application (2017-2022) & (Kg)

Table 48. APAC Ofatumumab Sales Market Share by Application (2017-2022)

Table 49. Europe Ofatumumab Sales by Country (2017-2022) & (Kg)

Table 50. Europe Ofatumumab Sales Market Share by Country (2017-2022)

Table 51. Europe Ofatumumab Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Ofatumumab Revenue Market Share by Country (2017-2022)

Table 53. Europe Ofatumumab Sales by Type (2017-2022) & (Kg)

Table 54. Europe Ofatumumab Sales Market Share by Type (2017-2022)

Table 55. Europe Ofatumumab Sales by Application (2017-2022) & (Kg)

Table 56. Europe Ofatumumab Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Ofatumumab Sales by Country (2017-2022) & (Kg)

Table 58. Middle East & Africa Ofatumumab Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Ofatumumab Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Ofatumumab Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Ofatumumab Sales by Type (2017-2022) & (Kg)

Table 62. Middle East & Africa Ofatumumab Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Ofatumumab Sales by Application (2017-2022) & (Kg)

Table 64. Middle East & Africa Ofatumumab Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Ofatumumab

Table 66. Key Market Challenges & Risks of Ofatumumab

Table 67. Key Industry Trends of Ofatumumab

Table 68. Ofatumumab Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Ofatumumab Distributors List

Table 71. Ofatumumab Customer List

Table 72. Global Ofatumumab Sales Forecast by Region (2023-2028) & (Kg)

Table 73. Global Ofatumumab Sales Market Forecast by Region

Table 74. Global Ofatumumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Ofatumumab Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Ofatumumab Sales Forecast by Country (2023-2028) & (Kg)

Table 77. Americas Ofatumumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Ofatumumab Sales Forecast by Region (2023-2028) & (Kg)

Table 79. APAC Ofatumumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Ofatumumab Sales Forecast by Country (2023-2028) & (Kg)

Table 81. Europe Ofatumumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Ofatumumab Sales Forecast by Country (2023-2028) & (Kg)

Table 83. Middle East & Africa Ofatumumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Ofatumumab Sales Forecast by Type (2023-2028) & (Kg)

Table 85. Global Ofatumumab Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Ofatumumab Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Ofatumumab Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Ofatumumab Sales Forecast by Application (2023-2028) & (Kg)

Table 89. Global Ofatumumab Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Ofatumumab Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Ofatumumab Revenue Market Share Forecast by Application (2023-2028)

Table 92. BOC Sciences Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors

Table 93. BOC Sciences Ofatumumab Product Offered

Table 94. BOC Sciences Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 95. BOC Sciences Main Business

Table 96. BOC Sciences Latest Developments

Table 97. GlaxoSmithKline(GSK) Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors

Table 98. GlaxoSmithKline(GSK) Ofatumumab Product Offered

Table 99. GlaxoSmithKline(GSK) Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 100. GlaxoSmithKline(GSK) Main Business

Table 101. GlaxoSmithKline(GSK) Latest Developments

Table 102. Lonza Group Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors

Table 103. Lonza Group Ofatumumab Product Offered

Table 104. Lonza Group Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 105. Lonza Group Main Business

Table 106. Lonza Group Latest Developments

Table 107. Novartis International Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors

Table 108. Novartis International Ofatumumab Product Offered

Table 109. Novartis International Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 110. Novartis International Main Business

Table 111. Novartis International Latest Developments

Table 112. TargetMol Chemicals Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors

Table 113. TargetMol Chemicals Ofatumumab Product Offered

Table 114. TargetMol Chemicals Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 115. TargetMol Chemicals Main Business

Table 116. TargetMol Chemicals Latest Developments

Table 117. Hubei Kele Fine Chemical Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors

Table 118. Hubei Kele Fine Chemical Ofatumumab Product Offered

Table 119. Hubei Kele Fine Chemical Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 120. Hubei Kele Fine Chemical Main Business

Table 121. Hubei Kele Fine Chemical Latest Developments

Table 122. Jiangxi Ruiweier Biotechnology Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors

Table 123. Jiangxi Ruiweier Biotechnology Ofatumumab Product Offered

Table 124. Jiangxi Ruiweier Biotechnology Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 125. Jiangxi Ruiweier Biotechnology Main Business

Table 126. Jiangxi Ruiweier Biotechnology Latest Developments

Table 127. Nantong Feiyu Biological Technology Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors

Table 128. Nantong Feiyu Biological Technology Ofatumumab Product Offered

Table 129. Nantong Feiyu Biological Technology Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 130. Nantong Feiyu Biological Technology Main Business

Table 131. Nantong Feiyu Biological Technology Latest Developments

Table 132. Shanghai Biochempartner Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors

Table 133. Shanghai Biochempartner Ofatumumab Product Offered

Table 134. Shanghai Biochempartner Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 135. Shanghai Biochempartner Main Business

Table 136. Shanghai Biochempartner Latest Developments

Table 137. Shanghai Macklin Biochemical Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors

Table 138. Shanghai Macklin Biochemical Ofatumumab Product Offered

Table 139. Shanghai Macklin Biochemical Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 140. Shanghai Macklin Biochemical Main Business

Table 141. Shanghai Macklin Biochemical Latest Developments

Table 142. Shanghai Yifei Biotechnology Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors

Table 143. Shanghai Yifei Biotechnology Ofatumumab Product Offered

Table 144. Shanghai Yifei Biotechnology Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 145. Shanghai Yifei Biotechnology Main Business

Table 146. Shanghai Yifei Biotechnology Latest Developments

Table 147. Tianmen Hengchang Chemical Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors

Table 148. Tianmen Hengchang Chemical Ofatumumab Product Offered

Table 149. Tianmen Hengchang Chemical Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 150. Tianmen Hengchang Chemical Main Business

Table 151. Tianmen Hengchang Chemical Latest Developments

Table 152. Wuhan Topule Biopharmaceutical Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors

Table 153. Wuhan Topule Biopharmaceutical Ofatumumab Product Offered

Table 154. Wuhan Topule Biopharmaceutical Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 155. Wuhan Topule Biopharmaceutical Main Business

Table 156. Wuhan Topule Biopharmaceutical Latest Developments

Table 157. Wuhan Wogeda Biotechnology Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors

Table 158. Wuhan Wogeda Biotechnology Ofatumumab Product Offered

Table 159. Wuhan Wogeda Biotechnology Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 160. Wuhan Wogeda Biotechnology Main Business

Table 161. Wuhan Wogeda Biotechnology Latest Developments

Table 162. Wuhan Yingnuo Pharmaceutical Technology Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors

Table 163. Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Product Offered

Table 164. Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 165. Wuhan Yingnuo Pharmaceutical Technology Main Business

Table 166. Wuhan Yingnuo Pharmaceutical Technology Latest Developments

List of Figures

Figure 1. Picture of Ofatumumab

Figure 2. Ofatumumab Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Ofatumumab Sales Growth Rate 2017-2028 (Kg)

Figure 7. Global Ofatumumab Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Ofatumumab Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Patent

Figure 10. Product Picture of Generic

Figure 11. Global Ofatumumab Sales Market Share by Type in 2021

Figure 12. Global Ofatumumab Revenue Market Share by Type (2017-2022)

Figure 13. Ofatumumab Consumed in Chemical

Figure 14. Global Ofatumumab Market: Chemical (2017-2022) & (Kg)

Figure 15. Ofatumumab Consumed in Pharmaceutical

Figure 16. Global Ofatumumab Market: Pharmaceutical (2017-2022) & (Kg)

Figure 17. Global Ofatumumab Sales Market Share by Application (2017-2022)

Figure 18. Global Ofatumumab Revenue Market Share by Application in 2021

Figure 19. Ofatumumab Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Ofatumumab Revenue Market Share by Company in 2021

Figure 21. Global Ofatumumab Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Ofatumumab Revenue Market Share by Geographic Region in 2021

Figure 23. Global Ofatumumab Sales Market Share by Region (2017-2022)

Figure 24. Global Ofatumumab Revenue Market Share by Country/Region in 2021

Figure 25. Americas Ofatumumab Sales 2017-2022 (Kg)

Figure 26. Americas Ofatumumab Revenue 2017-2022 ($ Millions)

Figure 27. APAC Ofatumumab Sales 2017-2022 (Kg)

Figure 28. APAC Ofatumumab Revenue 2017-2022 ($ Millions)

Figure 29. Europe Ofatumumab Sales 2017-2022 (Kg)

Figure 30. Europe Ofatumumab Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Ofatumumab Sales 2017-2022 (Kg)

Figure 32. Middle East & Africa Ofatumumab Revenue 2017-2022 ($ Millions)

Figure 33. Americas Ofatumumab Sales Market Share by Country in 2021

Figure 34. Americas Ofatumumab Revenue Market Share by Country in 2021

Figure 35. United States Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Ofatumumab Sales Market Share by Region in 2021

Figure 40. APAC Ofatumumab Revenue Market Share by Regions in 2021

Figure 41. China Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Ofatumumab Sales Market Share by Country in 2021

Figure 48. Europe Ofatumumab Revenue Market Share by Country in 2021

Figure 49. Germany Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Ofatumumab Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Ofatumumab Revenue Market Share by Country in 2021

Figure 56. Egypt Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Ofatumumab Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Ofatumumab in 2021

Figure 62. Manufacturing Process Analysis of Ofatumumab

Figure 63. Industry Chain Structure of Ofatumumab

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles